We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.92%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$16.3B
AUM Growth
+$1.54B
(+10%)
Cap. Flow
+$794M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
20.21%
Holding
1,104
New
170
Increased
359
Reduced
380
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$274M |
| 2 |
General Motors
GM
|
+$175M |
| 3 |
Cigna
CI
|
+$139M |
| 4 |
Ford
F
|
+$133M |
| 5 |
Adobe
ADBE
|
+$128M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$193M |
| 2 |
Tesla
TSLA
|
+$181M |
| 3 |
Palo Alto Networks
PANW
|
+$164M |
| 4 |
Microsoft
MSFT
|
+$98.7M |
| 5 |
Cardinal Health
CAH
|
+$83.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29% |
| 2 | Healthcare | 13.57% |
| 3 | Consumer Discretionary | 12.65% |
| 4 | Financials | 12.35% |
| 5 | Industrials | 10.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Park Hotels & Resorts
PK
$3.08B
| $12.7M | 0.08% |
1,023,669
-61,325
| -6% | -$805K |
|
252
Customers Bancorp
CUBI
$2.66B
| $12.5M | 0.08% |
673,829
+486,812
| +260% | +$13.3M |
|
|
ICPT
253
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $12.4M | 0.08% |
923,369
+262
| +0% | +$4.53K |
|
254
Eagle Materials
EXP
$6.49B
| $12.4M | 0.08% |
84,360
+15,088
| +22% | +$2.14M |
|
|
GMS
255
DELISTED
GMS Inc
GMS
| $12.3M | 0.08% |
213,058
+19,038
| +10% | +$1.08M |
|
256
Harmony Biosciences
HRMY
$2.08B
| $12.3M | 0.08% |
376,386
-2,641
| -0.7% | -$120K |
|
257
8x8 Inc
EGHT
$279M
| $12.1M | 0.07% |
2,899,013
-40,192
| -1% | -$201K |
|
258
Toll Brothers
TOL
$14B
| $12M | 0.07% |
200,401
-132,119
| -40% | -$7.62M |
|
259
Sunstone Hotel Investors
SHO
$2.19B
| $12M | 0.07% |
1,216,598
-318,320
| -21% | -$3.23M |
|
260
Regenxbio
RGNX
$616M
| $12M | 0.07% |
632,378
+605,255
| +2,232% | +$13.4M |
|
261
Tandem Diabetes Care
TNDM
$1.27B
| $11.9M | 0.07% |
293,277
+278,048
| +1,826% | +$11.5M |
|
262
Protolabs
PRLB
$1.7B
| $11.9M | 0.07% |
+358,987
| New | +$11.1M |
|
263
Adient
ADNT
$1.69B
| $11.8M | 0.07% |
288,362
+180,989
| +169% | +$7.56M |
|
264
Deckers Outdoor
DECK
$14.1B
| $11.8M | 0.07% |
+157,344
| New | +$11M |
|
265
EOG Resources
EOG
$77.7B
| $11.6M | 0.07% |
100,860
-282,534
| -74% | -$34.3M |
|
266
OFG Bancorp
OFG
$2.21B
| $11.4M | 0.07% |
455,763
-23,565
| -5% | -$659K |
|
267
Cavco Industries
CVCO
$4.36B
| $11.3M | 0.07% |
35,614
+5,803
| +19% | +$1.61M |
|
268
Enova International
ENVA
$6.09B
| $11.3M | 0.07% |
253,374
+6,671
| +3% | +$303K |
|
269
Stewart Information Services
STC
$2.14B
| $11M | 0.07% |
272,331
+5,414
| +2% | +$237K |
|
270
Visteon
VC
$2.85B
| $11M | 0.07% |
69,983
-24,689
| -26% | -$3.82M |
|
271
Theravance Biopharma
TBPH
$873M
| $11M | 0.07% |
1,010,689
-21,625
| -2% | -$229K |
|
272
O-I Glass
OI
$1.18B
| $10.9M | 0.07% |
481,888
+58,838
| +14% | +$1.23M |
|
273
Dycom Industries
DY
$11.2B
| $10.9M | 0.07% |
+116,795
| New | +$10.9M |
|
274
Fluor
FLR
$6.54B
| $10.9M | 0.07% |
351,583
+234,607
| +201% | +$8.07M |
|
275
Dave & Buster's
PLAY
$357M
| $10.7M | 0.07% |
291,764
-207,534
| -42% | -$8.28M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2023 Portfolio in Review
As of Q1 2023, Jacobs Levy Equity Management held 1,104 positions worth $16.3B, up 10% from $14.8B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Jacobs Levy Equity Management deployed $794M of net new capital in Q1 2023, opening 170 new positions and adding to 359 existing holdings. Its largest new stake was Cigna: 475,901 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Humana, an estimated $193M trimmed.
- Jacobs Levy Equity Management's largest Q1 2023 buy was Cigna: 475,901 shares worth $122M.
- Jacobs Levy Equity Management added most to Apple in Q1 2023, an estimated $274M increase.
- Jacobs Levy Equity Management's biggest Q1 2023 reduction was Humana, cutting an estimated $193M.
- Jacobs Levy Equity Management fully exited PayPal in Q1 2023, selling an estimated $66.4M.
- Jacobs Levy Equity Management's ten largest holdings make up 20% of its $16.3B portfolio in Q1 2023.
- Jacobs Levy Equity Management opened 170 new positions and closed 160 in Q1 2023.
- Jacobs Levy Equity Management's portfolio value rose 10% quarter-over-quarter to $16.3B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2023, filed 15 May 2023.